| Omar Nehme, MD | |
|
13313 N Meridian Ave Bldg D, Oklahoma City, OK 73120-8380 | |
| (405) 755-4290 | |
| (405) 755-7773 |
| Full Name | Omar Nehme |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 13313 N Meridian Ave Bldg D, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427222561 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 26111 (Oklahoma) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 26111 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi St Alexius Health | Bismarck, ND | Hospital |
| St Vincent Hospital | Green bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Alexius Medical Center | 8426960865 | 205 |
| St Vincent Hospital-hospital Sisters-third Order Of St Francis | 5799694675 | 562 |
News Archive
Endo Pharmaceuticals today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for FORTESTA(TM) (testosterone) 2% Gel for men diagnosed with low testosterone (Low T), also known as hypogonadism.
The affordability of American medical care in the future will depend, in part, on the ability of physicians to simplify and economize, which are two things they've never been good at. With national health expenditures amounting to $2.6 trillion a year -; 45 percent of it paid by government -; prosperity and political stability may also be at stake.
A team of researchers led by Cleveland Clinic has published first-of-its-kind findings in Science Translational Medicine on a new method of restoring natural movement sensation in patients with prosthetic arms.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
USA Today, on how the new health law has started helping consumers: "Provisions of the health care reform law that took effect Sept. 23 prohibit some of the industry's most controversial practices." Insurers must now cover children with pre-existing conditions and cover preventive care for everyone.
› Verified 5 days ago
| Entity Name | St Alexius Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868429 PECOS PAC ID: 8426960865 Enrollment ID: O20031104000146 |
News Archive
Endo Pharmaceuticals today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for FORTESTA(TM) (testosterone) 2% Gel for men diagnosed with low testosterone (Low T), also known as hypogonadism.
The affordability of American medical care in the future will depend, in part, on the ability of physicians to simplify and economize, which are two things they've never been good at. With national health expenditures amounting to $2.6 trillion a year -; 45 percent of it paid by government -; prosperity and political stability may also be at stake.
A team of researchers led by Cleveland Clinic has published first-of-its-kind findings in Science Translational Medicine on a new method of restoring natural movement sensation in patients with prosthetic arms.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
USA Today, on how the new health law has started helping consumers: "Provisions of the health care reform law that took effect Sept. 23 prohibit some of the industry's most controversial practices." Insurers must now cover children with pre-existing conditions and cover preventive care for everyone.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Omar Nehme, MD 4401 W Memorial Rd, Suite 140, Oklahoma City, OK 73134-1785 Ph: (405) 952-3162 | Omar Nehme, MD 13313 N Meridian Ave Bldg D, Oklahoma City, OK 73120-8380 Ph: (405) 755-4290 |
News Archive
Endo Pharmaceuticals today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for FORTESTA(TM) (testosterone) 2% Gel for men diagnosed with low testosterone (Low T), also known as hypogonadism.
The affordability of American medical care in the future will depend, in part, on the ability of physicians to simplify and economize, which are two things they've never been good at. With national health expenditures amounting to $2.6 trillion a year -; 45 percent of it paid by government -; prosperity and political stability may also be at stake.
A team of researchers led by Cleveland Clinic has published first-of-its-kind findings in Science Translational Medicine on a new method of restoring natural movement sensation in patients with prosthetic arms.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
USA Today, on how the new health law has started helping consumers: "Provisions of the health care reform law that took effect Sept. 23 prohibit some of the industry's most controversial practices." Insurers must now cover children with pre-existing conditions and cover preventive care for everyone.
› Verified 5 days ago
Evelyn Lorents, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |